Cancer-associated gene abnormalities and chemosensitivity

M. Sakamoto, K. Umayahara, H. Sakamoto, K. Kawasaki, Y. Suehiro, T. Kunugi, T. Akiya, H. Iwabuchi, H. Sakunaga, T. Muroya, Y. Kikuchi, T. Sugishita, Y. Tenjin, J. W. Gray, T. Tanaka

Research output: Contribution to journalReview article

4 Scopus citations

Abstract

One of the most important clinical issues in cancer chemotherapy is the presence of intrinsic resistance or the appearance of acquired resistance against chemotherapy. As for intrinsic resistance, we had to perform direct chemo-sensitivity testing, or had to rely on the knowledge empirically acquired from randomized clinical trials. However, molecular or genetic markers associated with chemo-sensitivity have been reported recently. For example, inactivation of p53 or GML gene has been reported to be associated with chemo-resistance. Overexpression of topo-isomerase I has been reported to be associated with chemo-sensitivity to Topo I inhibitor. Overexpression of Thymidine Phosphorylase has been found to be associated with chemo-sensitivity to prodrug of 5-FU. By checking the status of such chemo-sensitivity markers prior to chemotherapy, it would be possible to predict the chemotherapeutic effect and even the necessity of the chemotherapy in the near future. In this article, we review the chemo-sensitivity markers reported so far, and methodology contributing to the discovery of new chemo-sensitivity markers. As a clinical study, 11 cases of ovarian cancer with high sensitivity to cisplatin-based chemotherapy and 29 cases of ovarian cancer with chemoresistance were analyzed by Comparative Genomic Hybridization (CGH). Copy number decrease in Xp, and copy number increase in 19q were observed in 13, 12 out of 29 resistant cases (45, 41%) and zero, 1 out of 11 sensitive cases (0, 9%), suggesting that -Xp and +19q were likely to be a genetic event associated with intrinsic drug-resistance (p = 0.006, 0.05, respectively). This effort should contribute to the discovery of new chemo-sensitivity and resistance markers.

Original languageEnglish (US)
Pages (from-to)1819-1831
Number of pages13
JournalGan to kagaku ryoho. Cancer & chemotherapy
Volume25
Issue number12
StatePublished - Oct 1998

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Fingerprint Dive into the research topics of 'Cancer-associated gene abnormalities and chemosensitivity'. Together they form a unique fingerprint.

  • Cite this

    Sakamoto, M., Umayahara, K., Sakamoto, H., Kawasaki, K., Suehiro, Y., Kunugi, T., Akiya, T., Iwabuchi, H., Sakunaga, H., Muroya, T., Kikuchi, Y., Sugishita, T., Tenjin, Y., Gray, J. W., & Tanaka, T. (1998). Cancer-associated gene abnormalities and chemosensitivity. Gan to kagaku ryoho. Cancer & chemotherapy, 25(12), 1819-1831.